News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
Presentation TCT 2018 The Case for Bivalirudin With Radial (and Femoral) Access Presenter: John A. Bittl, C. Michael Gibson, Carey D. Kimmelstiel September 23, 2018